Skip to content

Public FDA record

Z-2201-2026: Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application, loaded on the f

Recall record Z-2201-2026 for Medtronic Neuromodulation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2201-2026
Company in FDA record
Medtronic Neuromodulation
FDA classification date
May 14, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will not be delivered at the intended time, if at all.

Source facts

Action
Medtronic issued an URGENT: MEDICAL DEVICE CORRECTION notice to its consignees on 4/8/2026 via email and mail. The notice explained the issue with the device and provided the following: "Recommendations: Review the order of Flex Infusion steps for patients previously programmed in Flex Infusion Mode: Review the Session Report from the prior interrogation. Access the report via the A810 application by communicating with the pump, then navigating to Settings > Reports > Session Long Report, and review the patient s previous programming session. Within Current Settings, confirm that the steps and durations are listed in the correct chronological order. If steps are not in chronological time order, either change the timing of the steps so they appear in order or reprogram while adding steps in chronological time order. When programming in Flex Infusion mode: Program Flex Infusion steps in chronological order. Before completing programming, confirm on the Finish screen that all steps appear in chronological time order (earliest to latest). If steps are not in chronological time order, reorder. Actions: Share this notice with all those who need to be aware of this issue within your organization and maintain a copy of this notice in your records. Please complete and return the Customer Confirmation Form enclosed with this letter, acknowledging that you have received this information. The form may be emailed to neuro.quality@medtronic.com." For questions regarding this communication, please contact Medtronic Technical Services at 1-800-707-0933 or your local Medtronic representative.
Initiated
2026-04-08
Root cause
Under Investigation by firm
Distribution
Worldwide distribution.
Recall number
Z-2201-2026
Recall status
Open, Classified
CDRH record ID
219693
FDA classified
2026-05-14
Recall event number
98750

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗